Kevin Kalinsky

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  

Kevin Kalinsky
Nov 10, 2024, 13:41 | Blog
The most recent Breast Cancer Research Digest by Dana-Farber Cancer Institute
Dana-Farber’s Breast Oncology Center shared on X: "Check out the Breast Cancer Research Digest -…
Nov 2, 2024, 12:01 | Positive
Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024
As Pink October has ended, it's time to reflect on Breast Cancer Awareness Month. OncoDaily…
Nov 2, 2024, 02:08 | Insight
INAVO120: Inavolisib with Palbociclib–Fulvestrant Doubles PFS in PIK3CA-Mutated Breast Cancer
Guilherme Nader Marta, Oncology Fellow at Jules Bordet Institute, shared a post by NEJM ,…
Oct 12, 2024, 10:30 | Insight
FDA Approves Inavolisib with Palbociclib and Fulvestrant for Advanced Breast Cancer
On October 10, 2024, the FDA approved inavolisib (Itovebi, Genentech, Inc.) in combination with palbociclib…
Sep 17, 2024, 15:01 | Blog
Rebecca Shatsky: Post-breast session at ESMO24
Rebecca Shatsky shared a post on X: ''Post-breast session at ESMO24. With the beloved ⁦Kevin…
Sep 14, 2024, 00:00 | Insight
Komal Jhaveri: The triplet with fulvestrant backbone yielded a mPFS of 35 months in HER2-negative breast cancer
Komal Jhaveri, Patricia and James Cayne Chair for Junior Faculty, Associate Member, Breast Medicine and…
Aug 27, 2024, 17:21 | Insight
Review of precision therapeutics and emerging strategies in HR+ MBC
Michelle DeMeo, Senior Program Manager at Dana-Farber Cancer Institute, shared on X: "Congratulations to Maxwell…
Aug 5, 2024, 01:55 | Societies
Scientific Committees at the ESMO Congress 2024
The ESMO Congress is a globally influential oncology platform that brings together clinicians, researchers, patient…
Jul 30, 2024, 07:55 | Societies
FASCO Recipients for this quarter - Part 1
FASCO Recipients - Part 1 ASCO recently shared on X: "Join us in congratulating our…
Jul 29, 2024, 08:28 | Blog
Sarah Louden: Don’t underestimate the power of democratizing education!
Sarah Louden, Founder and CEO at Total Health, shared a post on LinkedIn: "ASCO Direct Charlotte.…
Jul 11, 2024, 15:22 | Career
FASCO24 Designation Recipients
The Fellow of the American Society of Clinical Oncology (FASCO) distinction recognizes members for their…
Jul 9, 2024, 08:03 | Blog
Christine Hodgdon: We lost a beautiful, smiley, beloved member of our GRASP team
Christine Hodgdon, Breast Cancer Survivor and Advocate treated at Johns Hopkins, shared on X: "We lost…
Jun 5, 2024, 10:34 | Blog
Yara Abdou: Spectacular work by Kevin Kalinsky at ASCO24
Yara Abdou, Assistant Professor at University of North Carolina at Chapel Hill, shared on X/Twitter:…
May 5, 2024, 23:12 | Career
Kevin Kalinsky and Jane Meisel have been named chairs elect of two committees of ASCO
Winship Cancer Institute of Emory University announced on their X/Twitter page: “Winship medical oncologists Kevin Kalinsky,…
Apr 29, 2024, 10:43 | Blog
Stephanie Graff: Getting excited for ASCO24. Abstract titles are officially out
Stephanie Graff shared a post on X: "Getting excited for ASCO24 Annual Meeting. Abstract titles are…
Mar 1, 2024, 03:42 | Blog
Sarah Louden: The University of Kansas Cancer Center Breast Cancer Year in Review!
Sarah Louden, Founder and CEO at Total Health, recently shared on LinkedIn: "Another incredible conference! The…
Feb 25, 2024, 15:15 | Career
Kevin Kalinsky has been named director for the Division of Medical Oncology in Emory's Department of Hematology and Medical Oncology - Winship Cancer Institute of Emory University
Oct 18, 2023, 16:54 | Blog
Join us for an upcoming webinar on Precision Oncology on November 13, 2023 - The Multinational Association of Supportive Care in Cancer (MASCC)
The Multinational Association of Supportive Care in Cancer (MASCC) shared on LinkedIn: "Join us for…
All: 18 Posts: 1 - 100
Special Coverage